Switch theme
Sign up to access all valuation multiples
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.
2014
1.9K+
LTM Revenue $1.2B
LTM EBITDA $169M
$1.7B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Phibro Animal Health has a last 12-month revenue (LTM) of $1.2B and a last 12-month EBITDA of $169M.
In the most recent fiscal year, Phibro Animal Health achieved revenue of $1.0B and an EBITDA of $69.1M.
Phibro Animal Health expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Phibro Animal Health valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $1.2B | XXX | $1.0B | XXX | XXX | XXX |
| Gross Profit | $344M | XXX | $313M | XXX | XXX | XXX |
| Gross Margin | 29% | XXX | 31% | XXX | XXX | XXX |
| EBITDA | $169M | XXX | $69.1M | XXX | XXX | XXX |
| EBITDA Margin | 14% | XXX | 7% | XXX | XXX | XXX |
| EBIT | $120M | XXX | $53.3M | XXX | XXX | XXX |
| EBIT Margin | 10% | XXX | 5% | XXX | XXX | XXX |
| Net Profit | $33.8M | XXX | $2.4M | XXX | XXX | XXX |
| Net Margin | 3% | XXX | 0% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $417M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Phibro Animal Health's stock price is $24.
Phibro Animal Health has current market cap of $989M, and EV of $1.7B.
See Phibro Animal Health trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.7B | $989M | XXX | XXX | XXX | XXX | $1.76 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Phibro Animal Health has market cap of $989M and EV of $1.7B.
Phibro Animal Health's trades at 1.5x EV/Revenue multiple, and 13.9x EV/EBITDA.
Equity research analysts estimate Phibro Animal Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Phibro Animal Health has a P/E ratio of 29.2x.
See valuation multiples for Phibro Animal Health and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $989M | XXX | $989M | XXX | XXX | XXX |
| EV (current) | $1.7B | XXX | $1.7B | XXX | XXX | XXX |
| EV/Revenue | 1.4x | XXX | 1.5x | XXX | XXX | XXX |
| EV/EBITDA | 10.0x | XXX | 13.9x | XXX | XXX | XXX |
| EV/EBIT | 14.1x | XXX | 19.2x | XXX | XXX | XXX |
| EV/Gross Profit | 4.9x | XXX | n/a | XXX | XXX | XXX |
| P/E | 29.2x | XXX | 50.7x | XXX | XXX | XXX |
| EV/FCF | 47.8x | XXX | 41.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialPhibro Animal Health's last 12 month revenue growth is 10%
Phibro Animal Health's revenue per employee in the last FY averaged $0.5M, while opex per employee averaged $0.1M for the same period.
Phibro Animal Health's rule of 40 is 19% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Phibro Animal Health's rule of X is 39% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Phibro Animal Health and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 10% | XXX | 9% | XXX | XXX | XXX |
| EBITDA Margin | 14% | XXX | 11% | XXX | XXX | XXX |
| EBITDA Growth | 14% | XXX | 45% | XXX | XXX | XXX |
| Rule of 40 | 19% | XXX | 21% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 39% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.5M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 26% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
| Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
| Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
| Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
| Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Phibro Animal Health acquired XXX companies to date.
Last acquisition by Phibro Animal Health was XXXXXXXX, XXXXX XXXXX XXXXXX . Phibro Animal Health acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Phibro Animal Health founded? | Phibro Animal Health was founded in 2014. |
| Where is Phibro Animal Health headquartered? | Phibro Animal Health is headquartered in United States of America. |
| How many employees does Phibro Animal Health have? | As of today, Phibro Animal Health has 1.9K+ employees. |
| Who is the CEO of Phibro Animal Health? | Phibro Animal Health's CEO is Mr. Jack Clifford Bendheim. |
| Is Phibro Animal Health publicy listed? | Yes, Phibro Animal Health is a public company listed on NAS. |
| What is the stock symbol of Phibro Animal Health? | Phibro Animal Health trades under PAHC ticker. |
| When did Phibro Animal Health go public? | Phibro Animal Health went public in 2014. |
| Who are competitors of Phibro Animal Health? | Similar companies to Phibro Animal Health include e.g. Julphar, Benevolent AI, Galapagos, Pharming. |
| What is the current market cap of Phibro Animal Health? | Phibro Animal Health's current market cap is $989M |
| What is the current revenue of Phibro Animal Health? | Phibro Animal Health's last 12 months revenue is $1.2B. |
| What is the current revenue growth of Phibro Animal Health? | Phibro Animal Health revenue growth (NTM/LTM) is 10%. |
| What is the current EV/Revenue multiple of Phibro Animal Health? | Current revenue multiple of Phibro Animal Health is 1.4x. |
| Is Phibro Animal Health profitable? | Yes, Phibro Animal Health is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Phibro Animal Health? | Phibro Animal Health's last 12 months EBITDA is $169M. |
| What is Phibro Animal Health's EBITDA margin? | Phibro Animal Health's last 12 months EBITDA margin is 14%. |
| What is the current EV/EBITDA multiple of Phibro Animal Health? | Current EBITDA multiple of Phibro Animal Health is 10.0x. |
| What is the current FCF of Phibro Animal Health? | Phibro Animal Health's last 12 months FCF is $35.3M. |
| What is Phibro Animal Health's FCF margin? | Phibro Animal Health's last 12 months FCF margin is 3%. |
| What is the current EV/FCF multiple of Phibro Animal Health? | Current FCF multiple of Phibro Animal Health is 47.8x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
